A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

June 30, 2003

Conditions
Bronchitis, Chronic
Interventions
DRUG

Amoxicillin/clavulinic acid

amoxicillin/clavulinic acid 500 mg/62.5 mg tablet; take 2 tablets by mouth twice daily (BID) for 10 days

DRUG

Azithromycin

Azithromycin 250 mg tablet; take 2 tablets by mouth on the first day, then 1 tablet by mouth from Days 2 to 5

Trial Locations (31)

21000

Pfizer Investigational Site, Dijon

50120

Pfizer Investigational Site, Équeurdreville-Hainneville

54000

Pfizer Investigational Site, Nancy

54350

Pfizer Investigational Site, Mont-Saint-Martin

59150

Pfizer Investigational Site, Wattrelos

59200

Pfizer Investigational Site, Tourcoing

59410

Pfizer Investigational Site, Anzin

59600

Pfizer Investigational Site, Maubeuge

69001

Pfizer Investigational Site, Lyon

75012

Pfizer Investigational Site, Paris

75017

Pfizer Investigational Site, Paris

75020

Pfizer Investigational Site, Paris

76120

Pfizer Investigational Site, Le Grand-Quevilly

76150

Pfizer Investigational Site, Maromme

78200

Pfizer Investigational Site, Mantes-la-Jolie

78740

Pfizer Investigational Site, VAUX S/ Seine

84000

Pfizer Investigational Site, Avignon

91330

Pfizer Investigational Site, Yerres

91600

Pfizer Investigational Site, Savigny

94300

Pfizer Investigational Site, Vincennes

94460

Pfizer Investigational Site, Valenton

94800

Pfizer Investigational Site, Villejuif

84 000

Pfizer Investigational Site, Avignon

59 124

Pfizer Investigational Site, Escaudain

93 260

Pfizer Investigational Site, Les Lilas

13 008

Pfizer Investigational Site, Marseille

75 016

Pfizer Investigational Site, Paris

19 130

Pfizer Investigational Site, Saint-Aulaire

02 200

Pfizer Investigational Site, Soissons

26 790

Pfizer Investigational Site, Tulette

94 400

Pfizer Investigational Site, Vitry

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY